First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

A. Atieh, A. Obiedat, A. Vitenshtein, G. Cinamon, K. Paz, T. Roviš, P. Kucan, L. Hirsl, O. Mandelboim, S. Jonjic, T. Pini

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Pages (from-to)S69-S70
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

Cite this